Literature DB >> 2551729

The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors.

E Rochard1, D Legrand, J Mazurier, J Montreuil, G Spik.   

Abstract

Human lactotransferrin receptors have been recently characterized on mitogen-stimulated human lymphocytes [(1989) Eur. J. Biochem. 179, 481-487]. In order to define the lactotransferrin recognition site by these receptors, the binding to lymphocytes of several tryptic fragments, isolated from human lactotransferrin by mild tryptic hydrolysis [(1984) Biochim. Biophys. Acta 787, 90-96], has been investigated. The 30 kDa N-tryptic fragment (residues 4-281) and the re-associated N,C-tryptic complex bind to lactotansferrin lymphocyte receptor with a dissociation constant of 44 nM and 39 nM, respectively, similar to the value obtained for the native lactotransferrin (Kd = 46 nM). However, neither the N-terminal domain II (residues 91-257) nor the 50 kDa C-tryptic fragment (residues 282-703) are recognized. These results suggest that the binding site of human lactotransferrin by the lymphocyte receptor is located in the N-terminal lobe and more precisely in the N-terminal domain I (residues 4-90 and/or 258-281).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551729     DOI: 10.1016/0014-5793(89)81091-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.

Authors:  D Legrand; J Mazurier; P Maes; E Rochard; J Montreuil; G Spik
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Isolated rat hepatocytes differentially bind and internalize bovine lactoferrin N- and C-lobes.

Authors:  M P Sitaram; D D McAbee
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation.

Authors:  T W Hutchens; J F Henry; T T Yip
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus.

Authors:  Yasushi A Suzuki; Henry Wong; Kin-Ya Ashida; Anthony B Schryvers; Bo Lönnerdal
Journal:  Biochemistry       Date:  2008-09-12       Impact factor: 3.162

6.  Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.

Authors:  A M Schmidt; S D Yan; J Brett; R Mora; R Nowygrod; D Stern
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Authors:  E Elass-Rochard; A Roseanu; D Legrand; M Trif; V Salmon; C Motas; J Montreuil; G Spik
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

8.  Lactoferrin binds to porins OmpF and OmpC in Escherichia coli.

Authors:  J Erdei; A Forsgren; A S Naidu
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.